TRPC1 down-regulation along with SOC entry inhibition can result in reduced cyclin levels, G0/G1 cell cycle arrest and decreased cell growth in non-small cell lung carcinoma cell lines [26]. Here, UBXN11 is linked to non-small cell lung carcinoma.